Arthur M Krieg Checkmate Pharmaceuticals, Inc. (CMPI) insider trading activity
Arthur M Krieg is Chief Scientific Officer of Checkmate Pharmaceuticals, Inc.. Currently has a direct ownership of 815,734 shares of CMPI, which is worth approximately $8.56 Million. The most recent transaction as insider was on Jun 18, 2021, when has been sold 7,224 shares (Common Stock) at a price of $6.04 per share, resulting in proceeds of $43,633. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
816K
0%
3M change
0%
12M change
Total Value Held
$8.56 Million
Arthur M Krieg Transaction History
AMK
Arthur M Krieg
Chief Scientific Officer
Cambridge, MA